Introduction
Antigen recognition by T lymphocytes is mediated through the T-cell receptor (TcR) complex, an assembly of three distinct transmembrane components: an at3 or yd heterodimer, which can physically interact with antigenic peptides; CD3, a group of three distinct polypeptides; and a chain homodimer [ 11. How this complex mediates signal transduction upon binding to foreign peptides has not yet been elucidated. Nonetheless, changes in a variety of second messengers have been described upon signalling through the TcR complex including changes in tyrosine phosphorylation, an increase in intracellular calcium, phosphoinositol turnover, and activation of p21" [Z, 31.
An increase in tyrosine phosphorylation is one of the earliest events that occurs upon stimulation of the TcR complex, implicating the activation of a protein tyrosine kinase [2] . However, none of the known components of the TcR complex contains protein tyrosine kinase activity and thus the kinase that is activated is unknown. Possible candidates include members of the src family of protein tyrosine kinases, p 5 w and p56Ick, which have been found to associate with the TcR complex or the associated proteins CD4 or CD8 respectively [4-61.
Abbreviations used: TcR, T-cell receptor; PTPase, protein tyrosine phosphatase.
These proteins have been indirectly implicated in TcR activation [7-91. It was a surprise, therefore, when CD45, a transmembrane protein tyrosine phosphatase (PTPase) expressed uniquely by nucleated cells of haematopoietic origin, was also implicated in initial events in antigen-induced signalling. Cross-linking of CD45 with other cell-surface molecules has modulatory effects on proliferation and secondmessenger pathways [ 10, 111. Strong evidence for a direct role of CD45 in TcR-mediated signalling has come from the analysis of CD45-deficient lymphoid cell lines [12-151. Our work on CD45-deficient cells will be discussed in more detail below. These studies indicated that CD45 deficiencies render the T cell unable to respond to a TcR stimulus and implicate a dephosphorylation event early in antigen-induced activation.
CD45 consists of a heavily glycosylated Nterminal exterior domain, a single membranespanning region and a large C-terminal domain that contains PTPase activity [ 161. The exterior domain can be loosely divided into three regions: an immediate N-terminal region that contains numerous 0-linked sites and two non-homologous regions that are rich in cysteine residues. There are numerous N-linked carbohydrate sites scattered throughout the molecule. The 0-linked carbohydrate region is of interest because the absolute size of this domain changes in lymphocyte differentiation and activation. This is owing to the variable use of three exons regulated by alternative splicing. Therefore, the size of the 0-linked carbohydrate region is tightly regulated, which suggests that interactions with this mucin region will have functional consequences.
The cytoplasmic region contains two PTPase domains linked in tandem, however, only the first domain has been demonstrated to have activity [ 17, 181 . The function of the second domain is not known but may serve to regulate the first domain. Irregardless, the over-riding control of CD45-PTPase activity must reside with interactions of the exterior domain. How the exterior domain controls PTPase activity is a key question in understanding the interactions of CD45 in TcR activation.
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Analysis of CD45-deficient T-cell clones
T o pursue the function of CD45, T-cell clones were rendered CD45 deficient by non-specific mutagenesis and selection with antibody and complement [12, 151. Clones of both CD4+ and CD8' lineages were obtained that were defective in the biosynthesis of CD45. The CD4+ clone biosynthetically synthesizes CD45 but lacks surface expression, producing a form that is trapped in an intracellular compartment and of identical molecular mass to the immature glycosylated form. The CD8 + cells either do not transcribe CD45 mRNA or else produce an mFWA that is rapidly degraded. Upon stimulation with antigen or cross-linking of the TcR through anti-CD3 antibody both lineages were unable to proliferate. Furthermore, TcR stimulation was unable to properly induce cytokine production. The CD8+ T-cell clones were also greatly impaired in cytolytic function. Both antigen and anti-CD3 bound to target Fc-receptors were unable to elicit cytolytic function, thus indicating an impairment of TcR signal transduction and not merely an inability to recognize antigen. These data support a critical role for CD45 in TcR-mediated signalling. CD45+ revertants for both lineages were isolated and the ability to respond to antigen was restored. The inability to respond to antigen appropriately by the production of cytokines, proliferation, and cytolysis of target cells, suggest that the functional defect is immediate to TcR signalling; to transduce the antigen signal through the TcR requires the CD45 PTPase. Analysis of changes in protein tyrosine phosphorylation between parent and mutant cells should be informative.
There are important differences between the CD4+ and CD8+ CD45-deficient clones. The nature of the mutation is clearly different between these two types of clones. Furthermore, unlike CD8+ mutants, the CD4' mutants have a strikingly altered morphology in comparison with the parent clone ( Fig. 1) . The CD4+ CD45-cells generally have an increased cell volume, are spherical in shape, and are much less adherent to the culture dish when activated to divide (by interleukin-Z), possibly reflecting cytoskeletal alterations in these cells. Additionally, the CD4' CD45-mutants tend to grow in large clusters and appear to undergo a moderate degree of spontaneous cell death. The CD8' CD45-clones have minimal, but distinct, morphological changes compared with the parent clone. The significance of the morphological alterations between the CD4'-and CD8' CD45-clones is unknown, but is of interest because it may indicate that the full range of CD45 functions extends beyond its role in TcR signal transduction and differs in CD4' and CD8' T-cells. Alternatively, it may reflect differences in downstream events or non-specific effects related to differences in the types of mutations between the two sets of clones. In either case, the derivation of additional CD45-deficient CD4+ and CD8' clones will be instructive.
Finally, the CD4' CD45-deficient cells are incapable of signalling in response to antigen or anti-CDR, whereas, the CD8 ' mutants maintained limited function. It is possible that this may reflect a difference in signalling between the CD4' and CD8+ lineages and there is precedent to support differences in TcR-mediated signalling between different lineages [ 19, 201.
CD45 exterior domain
The interactions of the exterior domain of CD45 are unknown. T o examine potential interactions, a cDNA was constructed that consisted of bp 1-1803 (derived from a cDNA encoding the high-molecular-mass isoform) and encoded the leader sequence and virtually the entire exterior domain [ZI] . The cDNA, engineered into the BMG expression vector [22] , was used to transfect the 1,929 fibroblastoid line. Stable transfectants expressed a soluble secreted form at approximately 1 pg/ml. The soluble form was purified by affinity chromatography and yielded a single 160 kDa glycoprotein as determined by SDSIPAGE (Fig. 2) .
Potential interactions of the CD45 exterior domain were examined by either modulation of functional assays or by binding experiments. Purified CD45 exterior domain added at varying concentrations to antigen-stimulated CD4' T-cell clones did not significantly affect the proliferation when compared with buffer controls (Fig. 3a) . Likewise, addition of the CD45 exterior domain did not inhibit CD8+ T-cell clones in their ability to cyto- Affinity-purified soluble CD45 (high-molecular-mass isoform) lyse appropriate targets (Fig. 3b) . The same result was observed using the soluble form of the lowmolecular-mass CD45 isoform (data not shown). These data taken together suggest that the purified exterior domain does not effect functional assays and does not inhibit T cells in their ability to bind antigen-presenting cells or to bind to appropriate targets.
To assess whether the exterior domain could bind lymphoid cells, the purified glycoprotein was used to coat 96-well plates. Material was bound as assessed by an e.1.i.s.a. assay. RW5 147 (thymoma), 
Potential mechanisms of CD45 action
The requirement of CD45 in TcR signalling suggest that the dephosphorylation of at least one critical tyrosyl residue is needed, and multiple dephosphorylation events, either on a single protein or separate protein, are possible. Although the physiological substrates in T-cell activation are not yet fully characterized, two members of the src-gene family, ~5 6 "~ and p5*, have provocative associations with CD4 or CD8 [4, 51 and the TcR complex respectively [6]. These enzymes are regulated by tyrosine phosphorylation. Furthermore, pS6" is known to be a substrate for CD4S in vitro and in vivo [23-251. There are also other possible substrates for CD45 action. The t;-chain of the TcR complex is known to be phosphorylated on tyrosine residues [26-281, and CD45 could conceivably modulate signalling through the TcR complex by its action on 5;-chain phosphorylation. Current data are insufficient to distinguish between different mechanisms of CD45 action in TcR signalling. It should be emphasized, however, that the functional deficit observed in the C I M -mutants is most consistent with a positive rather than negative role for CD45 in signal transduction through the TcR complex. Accordingly, if it is assumed that tyrosine phosphorylation of the TcR t;-chain initiates the subsequent signalling cascade, CD45 might then act very proximally by dephosphorylating and thus activating a PTPase (p56"' or p59fi") that Volume 20 could then phosphorylate tyrosine residues on the [-chain. Absence of CD45 function in this case would predict that the TcR 5-chain would not be phosphorylated following antigen recognition. If, on the other hand, 5-chain tyrosine phosphorylation terminates further signalling through the TcR, as part of a mechanism for down-regulation of the activated complex, then CD45 might act later in the signalling cascade to directly dephosphorylate the [-chain and allow resignalling through the desensitized TcR. In this case, absence of CD45 function would lead to chronic phosphorylation of the 5-chain, resulting in a state of T-cell receptor unresponsiveness or anergy. The functional deficits of the CD45-mutants are compatible with either of these alternatives. Indeed, these two mechanisms might not be mutually exclusive. Thus, CD45 could function in either capacity, as both an initiator and terminator of TcR 5-chain phosphorylation through direct or indirect actions. Clearly, the CD45-deficient T-cell clones described herein should be valuable in exploring these possibilities.
The requirement for CD45 in specific TcR signalling is surprising given that CD45 is expressed by all nucleated haemotopoietic cells. Thus it is possible that the CD45 PTPase and members of the 5-chain family may be common signalling pathways in leucocytes.
If CD45 exterior domain interactions are important in modulating PTPase activity and these interactions are not intercellular, then it is possible that the interactions are within the same membrane. Sequestration of substrate may be important in regulating CD45 activity and it is possible that the exterior domain regulates the association with substrate. The various isoforms may associate with substrates at varying rates leading to a temporal control T-cell activation by determining the speed with which the signal is transduced. This hypothesis would explain our inability to affect functional assays or binding assays with the purified exterior domain. Furthermore, it would suggest that T cells that express different forms of CD45 would be activated at differing rates. intrinsic PTP activity [ 3 ] , suggesting that transmembrane PTPs might represent a novel class of receptors that oppose the action of protein tyrosine kinases (PTKs) and play a fundamental role in the regulation of cell growth and differentiation. In the past three years, substantial progress has been made in identifying other transmembrane and intracellular PTPs in organisms as diverse as higher eukaryotes, yeast, bacteria, and viruses, and the complete primary structures of at least seven transmembrane and eight intracellular PTPs have been determined (reviewed in . However, relatively little is known about the mechanism of action, regulation, or physiological substrates of PTPs. Although CD45 is unusual in some respects, having a highly restricted tissue distribution, multiple isoforms, and an external domain unrelated to other PTPs, it is the best characterized of the transmembrane PTPs and serves as a prototype for this class of enzyme. In this paper, we describe our recent studies that provide strong evidence that ~5 6 ' "~ is a substrate of
